BSX vs FCN · P/E 20, rev $20.07B vs P/E 23, rev $1.98B
Boston Scientific Corp (BSX) versus FTI Consulting Inc (FCN) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
FTI Consulting Inc (FCN) is a consulting services company listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported FCN revenue for 2026-06-30 was $1.98B. Net income was $115.4M. FCN currently screens at market cap $5.70B and trailing P/E 22.7.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. FCN currently screens at market cap $5.70B and trailing P/E 22.7.
Not investment advice. Open the BSX and FCN stock pages for the full models.
Not investment advice.